Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
about
Treatments for preventing recurrence of infection withPseudomonas aeruginosain people with cystic fibrosisOral anti-pseudomonal antibiotics for cystic fibrosisCurrent and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implicationsPseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung InfectionsCurrent and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its SymptomsCarbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the PuzzleYear in review 2014: Interstitial lung disease, physiology, sleep and ventilation, acute respiratory distress syndrome, cystic fibrosis, bronchiectasis and rare lung diseaseThe Effect of Infection Control Nurses on the Occurrence of Pseudomonas aeruginosa Healthcare-Acquired Infection and Multidrug-Resistant Strains in Critically-Ill ChildrenAssessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".Azithromycin Attenuates Pseudomonas-Induced Lung Inflammation by Targeting Bacterial Proteins Secreted in the Cultured Medium.Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.Perception of first respiratory infection with Pseudomonas aeruginosa by people with cystic fibrosis and those close to them: an online qualitative studyManagement of Pseudomonas aeruginosa infection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacinAntibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.A multifunctional bispecific antibody against Pseudomonas aeruginosa as a potential therapeutic strategy.Brazilian guidelines for the diagnosis and treatment of cystic fibrosis.Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis.The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis.
P2860
Q26470661-63864A4C-C824-4DF5-80CA-F1AA9ED38DE4Q26471106-11630354-EE24-4983-9BB1-F148F1FFB5BBQ26747065-56CFD202-4AB5-4F33-9E91-786BFDE8ADDCQ26768034-33FC8F27-62C6-4AAA-838E-FD38650DA37EQ28077411-8B4246A3-4F1F-4DDB-B470-A158373A8D95Q28078925-632CD8EC-D3E2-4001-8CFB-B33E4B9E220AQ28085094-9EB4DB21-FB9F-4EA4-8ED0-4FDF4F5473B2Q28551240-C8122054-81EE-4902-B728-F64922F1A734Q35918209-873192BA-C58A-4390-83F3-867A9611375FQ36944153-C120B736-4D24-4C73-880A-4B737A7EC1D8Q37413404-1170BE1A-C560-452E-BB5C-CE95D4D656E8Q37538748-F9D578FD-6E46-4CCE-8586-F3B50CAEB25AQ37576913-9251DED1-DADD-4117-802B-B7969B435719Q38634682-41D80482-457C-41C8-A963-9BC3B4777C7FQ38821019-B6F33994-C406-40DF-88CC-D7DA5FB9F8E5Q40559360-73BD0D98-AD29-452F-A0A9-3B348087D0FFQ43083370-BEFE3EC1-8AED-499B-BE17-2E0F5EE72FA7Q43538692-8641B83D-B22C-4F3F-8575-E651388C6865Q47097212-F7D18E7A-52F0-4338-8B7E-735BE1338358Q47730320-23904BC1-0C66-4A8A-9160-FD418FFA788F
P2860
Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Antibiotic strategies for erad ...... in people with cystic fibrosis
@ast
Antibiotic strategies for erad ...... in people with cystic fibrosis
@en
Antibiotic strategies for erad ...... in people with cystic fibrosis
@nl
type
label
Antibiotic strategies for erad ...... in people with cystic fibrosis
@ast
Antibiotic strategies for erad ...... in people with cystic fibrosis
@en
Antibiotic strategies for erad ...... in people with cystic fibrosis
@nl
prefLabel
Antibiotic strategies for erad ...... in people with cystic fibrosis
@ast
Antibiotic strategies for erad ...... in people with cystic fibrosis
@en
Antibiotic strategies for erad ...... in people with cystic fibrosis
@nl
P2860
P3181
P1476
Antibiotic strategies for erad ...... in people with cystic fibrosis
@en
P2093
Simon C Langton Hewer
P2860
P304
P3181
P356
10.1002/14651858.CD004197.PUB4
P577
2014-11-10T00:00:00Z